This page lists healthtech venture capital firms across the United States, from seed specialists to multi-stage funds. Most are traditional VC firms backing seed and Series A rounds, and many also cover healthcare services, software, and AI. Check sizes cluster in two bands: checks of $1 million to $5 million and checks of $10 million to $50 million.
Healthtech venture capital in the United States
The US combines a large private payer market, dense academic medical centers, and a regulatory path that specialist investors know well. That mix gives founders in digital health, diagnostics, care delivery, and medical devices a deep pool of customers and investors who understand long sales cycles.
Nearly every firm here backs seed rounds, most also do Series A, and a smaller group follows companies into late stage. The list also includes firms that do private equity, corporate venture arms, angel investors, family offices, and a few debt funds. For wider lists, see top venture capital firms in the United States or top HealthTech venture capital firms.
Who backs health tech startups in the US
General Catalyst
General Catalyst is a San Francisco venture capital firm, founded in 2000, that puts healthcare and AI at the center of its strategy. It invests from seed to late stage with checks of $10 million to $50 million, which points to growth rounds, and runs the General Catalyst Health Assurance Fund II. Cityblock, a healthcare services company, is among its investments. A fit for founders rethinking how care is delivered or paid for.
Andreessen Horowitz
Andreessen Horowitz, known as a16z, was founded in 2009 in Menlo Park and invests as both a venture capital and private equity firm. It calls itself stage agnostic, backing companies from seed to late stage across bio and healthcare, enterprise, fintech, and crypto, with checks of $50 million to $100 million. Its funds include the Andreessen Horowitz Bio + Health Fund. Best for teams that want hands-on help from partners who were once founders and operators.
Khosla Ventures
Khosla Ventures is a Menlo Park venture capital firm started by Sun Microsystems co-founder Vinod Khosla, known for high-risk bets that challenge conventional thinking. Its health work spans digital health, medtech, and diagnostics, with Guardant Health (blood tests for cancer care) and AliveCor (cardiologic care using deep learning) in its portfolio. It typically invests from Series A onward, and its listed range is checks above $100 million. Founders with a contrarian technical thesis will get a hearing here.
GV (Google Ventures)
GV (Google Ventures) is the investment arm of Alphabet, founded in 2009 in Mountain View, so it acts as both a corporate VC and a venture capital investor. Healthcare sits next to AI applications, developer tools, and security in its focus, and insitro and Viz.ai are in its portfolio. Its listed range is checks of $1 million to $5 million, typical of seed to Series A, though it backs companies through late stage. Suited to AI-driven health startups.
New Enterprise Associates (NEA)
New Enterprise Associates (NEA), founded in 1977 and based in Menlo Park, invests as both a venture capital and private equity firm with domain expertise in healthcare and technology. It backs companies from seed through later rounds up to IPO, with checks of $10 million to $50 million, and its funds include NEA 18. A strong match for health companies that want one partner from inception to public listing.
Bessemer Venture Partners
Bessemer Venture Partners is a Redwood City venture capital firm with roots in 1911, covering healthcare, biotech, AI, and vertical software. It invests from seed to growth stage, lists checks above $100 million, and manages funds such as Bessemer Venture Partners VIII Institutional. Because it publishes its investment roadmaps, founders can test their healthcare software pitch against its theses before reaching out.
How to shortlist healthtech investors from this list
- Filter by stage first. Most firms here back seed and Series A, so late-stage founders should narrow the list early.
- Match check size to your round. Checks under $1 million suit pre-seed and seed; checks of $10 million to $50 million suit growth rounds.
- Look at the health sub-sector. Digital health, diagnostics, medtech, and care delivery need different expertise, so check each profile's portfolio.
- Note the firm type. Corporate VCs, family offices, and debt funds behave differently from classic VC funds. If you need a buyout or majority partner, see top HealthTech private equity firms in the United States.
Private Equity List gives you firm profiles, partner contacts, and filters by sector, stage, and check size, so you can build a focused investor list before your first outreach.